Catalysts About KORU Medical Systems KORU Medical Systems develops and supplies subcutaneous infusion systems and consumables used to deliver immunoglobulin and other specialty biologic drugs in home and clinic settings. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About KORU Medical Systems KORU Medical Systems develops and commercializes subcutaneous infusion systems and related consumables for immunoglobulin and other specialty biologic therapies worldwide. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About KORU Medical Systems KORU Medical Systems develops and commercializes subcutaneous drug delivery systems, focused on infusions for immunoglobulin therapies and other specialty biologics. What are the underlying business or industry changes driving this perspective?Read more
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
